A new Stanford study reveals risks in AI therapy chatbots, which shows they may stigmatise users and give unsafe responses in mental health support.

Glenmark’s progress with a cancer treatment shows the potential of Indian pharma to move from generics to drug discovery.

The finish line for this year’s AI sprint is Las Vegas in December, when Garman will host his first full re:Invent conference as chief executive. He promises a “lot of agentic news” and hints at ...